Description

The most complete training in the field of Pregnancy Pathologies for Midwives in the entire educational market: a broad and complete Professional Master’s Degree, unique in its specialty"

master patologias embarazo matronas

This Professional Master’s Degree has been created as a complete training tool for midwives in the field of neonatal pathologies, offering a complete and updated review of all new developments and advances in this field.

With 60 credits, it is also a highly qualified training leap for professionals in this branch of health. With the quality and attention to training efficiency that only TECH can put at your disposal.

A unique opportunity to take the leap towards excellence in your profession.

This Professional Master’s Degree includes absolutely everything related to obstetric pathology, always using the most updated guidelines that have been published, as well as all the information included in the protocols that govern their care work, such as those of the Spanish Society of Gynecology and Obstetrics and the World Health Organization.

Midwives work on a daily basis with pregnant women suffering from some type of pathology, whether or not derived from pregnancy, and training is sometimes scarce during residency.  

More and more maternity wards have a specific pathological pregnancy ward, and some midwives have not had a rotation during the two years of the specialty: this Professional Master’s Degree can be used to provide comprehensive training with scientific rigor to perform work based on the best scientific evidence.  
A novel and necessary approach to healthcare training that is the first of its kind.   

Become a highly qualified professional with this unique Professional Master’s Degree in Pregnancy Pathologies for Midwives"

This Professional Master’s Degree in Pregnancy Pathologies for Midwives offers you all the features of a high-level scientific, teaching, and technological course.  These are some of its most notable features:

  • Latest technology in online teaching software
  • Highly visual teaching system, supported by graphic and schematic contents that are easy to assimilate and understand
  • Practical cases presented by practising experts
  • State-of-the-art interactive video systems
  • Teaching supported by telepractice
  • Continuous updating and recycling systems
  • Self-regulating learning: full compatibility with other occupations
  • Practical exercises for self-evaluation and learning verification
  • Support groups and educational synergies: questions to the expert, debate and knowledge forums
  • Communication with the teacher and individual reflection work
  • Content that is accessible from any fixed or portable device with an Internet connection
  • Supplementary documentation databases are permanently available, even after the course

A Professional Master’s Degree that will enable you to face the most complex situations in the field of pregnancy pathologies, with the solvency of a high-level professional"

Our teaching staff is made up of professionals from different fields related to this specialty. In this way, we ensure that we provide you with the training update we are aiming for. A multidisciplinary team of professionals trained and experienced in different environments, who will cover the theoretical knowledge in an efficient way, but, above all, will put the practical knowledge derived from their own experience at the service of the course: one of the differential qualities of this course.

Command of the subject is complemented by the effectiveness of the methodological design of this TECH Professional Master’s Degree in Pregnancy Pathologies for Midwives. Developed by a multidisciplinary team of e-learning experts, it integrates the latest advances in educational technology. This way, you will be able to study with a range of comfortable and versatile multimedia tools that will give you the operability you need in your training.  

The design of this program is based on Problem-Based Learning: an approach that conceives learning as a highly practical process. To achieve this remotely, we will use telepractice:  with the help of an innovative interactive video system, and learning from an expert, you will be able to acquire the knowledge as if you were actually dealing with the scenario you are learning about. A concept that will allow you to integrate and fix learning in a more realistic and permanent way. 

A Professional Master’s Degree that will enable you to face the most complex situations in the field of pregnancy pathologies, with the solvency of a high-level professional"

maestria patologias embarazo matronas

With the experience of expert professionals who will contribute their experience in this field to the programme, making this training a unique opportunity for professional growth"

Syllabus

The contents of this Professional Master’s Degree have been developed by the different experts of this course with a clear purpose: to ensure that our students acquire each and every one of the skills required to become true experts in this field.  

A complete and well-structured program that will take you to the highest standards of quality and success.     

maestria online patologias embarazo matronas

A comprehensive teaching program, structured in well-developed teaching units, oriented towards learning that is compatible with your personal and professional life" 

Module 1. Concept of Gestational Risk. First Trimester Hemorrhage. Congenital Fetal Defects. Prenatal Diagnosis

1.1. Risk Pregnancy Approach.   

1.1.1. Socio-Demographic Risk 

 1.1.1.1. Adolescent Pregnancy. Special Considerations.  
 1.1.1.2. Mother with Drug Dependency Problems 

  1.1.1.2.1. Principles of Drug-Induced Teratogenesis 
  1.1.1.2.2. Alcohol  
  1.1.1.2.3. Cocaína 
  1.1.1.2.4. Heroin 
  1.1.1.2.5. Other Drugs: Marijuana, Cannabis 

1.1.2. Occupational Risk in Pregnancy. Ergonomics. Radiation Exposure.  
1.1.3. Reproductive Risk. (broken down throughout the course) 
1.1.4.  Risk for the Current Gestation. (broken down throughout the course) 
1.1.5. Medical Risk. (broken down throughout the course) 

1.2. Miscarriage: 

1.2.1. Definition and Epidemiology 
1.2.2. Main Causes of Abortion 
1.2.3. Clinical Forms of Abortion 

 1.2.3.1. Threat of Abortion 
 1.2.3.2. Abortion in Progress 
 1.2.3.3. Full Abortion 
 1.2.3.4. Partial Abortion 
 1.2.3.5. Delayed Abortion  
 1.2.3.6. Recurrent Miscarriages: Concept and Approach 

1.2.4. Diagnosis.  

 1.2.4.1. Medical history 
 1.2.4.2. Physical Exploration 
 1.2.4.3. Ultrasound  
 1.2.4.4. Determination of B-hCG 

1.2.5. Treatment of Miscarriage 

 1.2.5.1. Medical Treatment 
 1.2.5.2.Surgical Treatment 

1.2.6. Complications:  

 1.2.6.1. Sepsis or Septic Abortion 
 1.2.6.2. Hemorrhage and Disseminated Intravascular Coagulation (DIC) 

1.2.7. Postabortion Care 

1.3. Ectopic or Extrauterine Pregnancy:  

1.3.1. Concept and Risk Factors 
1.3.2. Clinical symptoms 
1.3.3. Clinical and Ultrasound Diagnosis 
1.3.3. Types of Extrauterine Gestation: Tubal, Ovarian, Abdominal, etc. 
1.3.4. Therapeutic Management and Aftercare 

1.4. Gestational Trophoblastic Disease:  

1.4.1. Concept 
1.4.2. Clinical Forms of Hydatidiform Mole 

 1.4.2.1. Partial Mole 
 1.4.2.2. Complete Mole 

1.4.3.  Clinical Forms of Trophoblastic Neoplasia 

 1.4.3.1. Invasive Mole and Placental Bed Tumor 
 1.4.3.2. Choriocarcinoma 

1.4.4. Clinical and Ultrasound Diagnosis 
1.4.5. Treatment 
1.4.6. Aftercare and Subsequent Complications 

1.5. Congenital Fetal Defects due to Genetic Causes 

1.5.1. Types of Chromosome Abnormalities 

 1.5.1.1. Aneuploidies 
 1.5.1.2. Structural Abnormalities 
 1.5.1.3. Gender-Linked Alterations 

1.5.2. Prenatal Diagnostic Techniques. Inclusion Criteria.  

 1.5.2.1. Invasive Techniques 
 1.5.2.2. Non-Invasive Techniques 

1.5.3. Genetic Counseling 

1.6. Congenital Fetal Defects Secondary to Infections: TORCH 

1.6.1. Toxoplasma 

 1.6.1.1. Etiologic Agent, Symptoms and Epidemiology 
 1.6.1.2. Prevention  
 1.6.1.3. Diagnosis 
 1.6.1.4. Treatment 
 1.6.1.5. Congenital Toxoplasma infection 

1.6.2. Rubella  

 1.6.2.1. Etiologic Agent, Symptoms and Epidemiology 
 1.6.2.2. Prevention and Vaccination 
 1.6.2.3. Diagnosis 
 1.6.2.4. Treatment 
 1.6.2.5. Congenital Rubella Infection 

1.7. Congenital Fetal Defects Secondary to Infections: TORCH (II) 

1.7.1. Cytomegalovirus 

 1.7.1.1. Etiologic Agent, Symptoms and Epidemiology 
 1.7.1.2. Prevention  
 1.7.1.3. Diagnosis 
 1.7.1.4. Treatment 
 1.7.1.5. Congenital Cytomegalovirus Infection 

1.7.2. Chickenpox 

 1.7.2.1. Etiologic Agent, Symptoms and Epidemiology 
 1.7.2.2. Prevention and Vaccination 
 1.7.2.3. Diagnosis 
 1.7.2.4. Treatment 
 1.7.2.5. Congenital Chickenpox Infection 
 1.7.2.6. Maternal Complications due to Chickenpox 

1.8. Congenital Fetal Defects Secondary to Infections: TORCH (III) 

1.8.1. Herpes Simplex Virus 

1.8.1.1. Etiologic Agent, Symptoms and Epidemiology 
1.8.1.2. Prevention 
1.8.1.3. Diagnosis 
1.8.1.4. Treatment 
1.8.1.5. Congenital Herpes Simplex Infection 

1.8.2. Syphilis 

 1.8.2.1. Etiologic Agent, Symptoms and Epidemiology 
 1.8.2.2. Prevention  
 1.8.2.3. Diagnosis 
 1.8.2.4. Treatment 
 1.8.2.5. Sifilis Congenita 

1.9. Other Infections Causing Fetal Problems 

1.9.1. Parvovirus B19

 1.9.1.1. Etiologic Agent, Symptoms and Epidemiology 
 1.9.1.2. Prevention  
 1.9.1.3. Diagnosis 
 1.9.1.4. Treatment 
 1.9.1.5. Congenital Parvovirus Infection 

1.9.2. Listeria 

 1.9.2.1. Etiologic Agent, Symptoms and Epidemiology 
 1.9.2.2. Prevention and Vaccination 
 1.9.2.3. Diagnosis 
 1.9.2.4. Treatment 
 1.9.2.5. Congenital Listeria Infection 

1.10. HIV and Gestation 

1.10.1. Epidemiology 
1.10.2. Gestational Screening and Diagnosis 
1.10.3. Clinical Management and Treatment 
1.10.4.  Delivery of an HIV-Positive Woman  
1.10.5. Neonatal Care and Vertical Infection 

Module 2.  Pregnant with Pathology Derived from the Digestive System

2.1. Neurovegetative Disorders:  

2.1.1. Appetite Disorders 
2.1.2. Sialorrhea
2.1.3. Nausea and Vomiting (Hyperemesis Gravidarum will be Described as a Separate Chapter due to its Importance and Incidence in Pregnancy).  

2.2. Hyperemesis Gravidarum:

2.2.1. Concept 
2.2.2. Aetiopathogenesis. 
2.2.3. Clinical Manifestations 
2.2.4. Diagnosis 
2.2.5. Treatment and Care 

2.3. Mouth Disorders:

2.3.1. Cavities During Pregnancy 
2.3.2. Epulis Gravidarum 
2.3.3. Gingivitis 
2.3.4. Perimilolysis 
2.3.5. Xerostomia 

2.4. Pyrosis and Peptic Ulcer in Pregnant Women 

2.4.1. Concept 
2.4.2. Effect of Pregnancy on Heartburn and Peptic Ulcer Disease 
2.4.3. Treatment and Hygienic Measures 

2.5. Constipation in Pregnancy 

2.5.1. Definition: ROMA Criteria 
2.5.2. Etiology 
2.5.3. Diagnosis 
2.5.4. Treatment 

 2.5.4.1. Non-Pharmacological Treatment 
 2.5.4.2. Pharmacological Treatment 

2.6. Inflammatory Bowel Disease:  

2.6.1. Crohn's Disease 

 2.6.1.1. Preconception Counseling 
 2.6.1.2. Impact of Gestation on the Disease 
 2.6.1.3. Diagnosis During Pregnancy 
 2.6.1.4. Treatment 

2.6.2. Ulcerative Colitis  

 2.6.2.1. Preconception Counseling 
 2.6.2.2. Impact of Gestation on the Disease 
 2.6.2.3. Diagnosis During Pregnancy 
 2.6.2.4. Treatment 

2.7. Appendicitis and Intestinal Obstruction 

2.7.1. Acute Appendicitis 

 2.7.1.1. Concept 
 2.7.1.2. Special Diagnostic Considerations in Pregnancy 
 2.7.1.3. Treatment 

2.7.2. Intestinal Obstruction 

 2.7.2.1. Concept 
 2.7.2.2. Special Diagnostic Considerations in Pregnancy 
 2.7.2.3. Treatment 

2.8. Gallbladder and Liver Pathology (Intrahepatic Cholestasis of Pregnancy and Chronic Viral Hepatitis are Treated in a Separate Chapter Due to Their Importance in Pregnancy) 

2.8.1. Cholecystitis 

 2.8.1.1. Special Diagnostic Considerations in Pregnancy 

2.8.2. Colelitiasis 

 2.8.2.1. Special Considerations and Handling in Pregnancy 

2.8.3. Fatty Liver or Acute Hepatic Degeneration:  

 2.8.3.1. Definition and Aetiology 
 2.8.3.2. Clinical symptoms 
 2.8.3.3. Diagnosis 
 2.8.3.4. Treatment  

2.9. Intrahepatic Cholestasis of Pregnancy:  

2.9.1. Concept 
2.9.2. Clinical symptoms 
2.9.3. Diagnosis 
2.9.4. Treatment  
2.9.5. Fetal Impact and Prognosis 

2.10. Chronic Viral Hepatitis and Gestation 

2.10.1. Hepatitis B 

 2.10.1.1. Epidemiology 
 2.10.1.2. Diagnosis and Screening  
 2.10.1.3. Clinical Management 
 2.10.1.4. Delivery of an HBV-Positive Woman 
 2.10.1.5. Neonatal Care and Vertical Infection 

2.10.2. Hepatitis C 

 2.10.2.1. Epidemiology 
 2.10.2.2. Diagnosis and Screening  
 2.10.2.3. Clinical Management 
 2.10.2.4. Delivery of an HCV-Positive Woman 
 2.10.2.5. Neonatal Care and Vertical Infection 

2.11. Pancreas. 

2.11.1. Acute Pancreatitis in Pregnancy 

 2.11.1.1. Concept and Risk Factors 
 2.11.1.2. Clinical symptoms 
 2.11.1.3. Treatment 

Module 3. Pregnant with Hematological and Cardiac Problems

3.1. Gestational Anemia:  

3.1.1. Concept 
3.1.2. Etiopathogenesis and Fetal Repercussion  
3.1.3. Types of Anemias:  

3.1.3.1. Microcytic Anemia 
3.1.3.2. Normocytic Anemia 
3.1.3.3. Macrocytic Anemia 

3.1.4. Treatment and Prophylaxis 
3.1.5. Other Forms of Anemia 

3.1.5.1. Faciform or Sickle Cell Anemia 
3.1.5.2. Thalassemia 

3.2.  Thrombocytopenias:  

3.2.1. Essential Thrombopenia of Pregnancy 

3.2.1.1. Causes and Incidence 
3.2.1.2. Diagnosis 
3.2.1.3. Obstetrical Behavior 

3.2.2. Idiopathic Thrombocytopenic Purpura 

3.2.2.1. Causes and Incidence 
3.2.2.2 Diagnosis 
3.2.2.3. Obstetrical Behavior 

3.2.3. Alloimmune Neonatal Thrombopenia 

3.2.3.1. Causes and Incidence 
3.2.3.2 Diagnosis 
3.2.3.3. Obstetrical Behavior 

3.2.4.  Thrombopenia Associated with Hypertensive States of Pregnancy (Module 9) 
3.2.5. Therapeutic Management of Thrombopenias in Pregnancy  
3.2.6.  Therapeutic Management of the Newborn of a Mother with Thrombopenia 

3.3. Coagulation Problems: 

3.3.1. Von Willebrand Disease  

3.3.1.1. Definition and Epidemiology 
3.3.1.2. Considerations in Birth 

3.3.2. Hemophilia 

3.3.2.1. Definition and Epidemiology 
3.3.2.2. Types  

 3.3.2.2.1. Haemophilia A 
 3.3.2.2.2. Hemophilia B 

3.3.2.3. Chromosomal Inheritance Patterns of Haemophilia 
3.3.2.4. Considerations in Birth 

3.4.  Varicose Syndrome:  

3.4.1. Concept and Pathophysiology 
3.4.2. Clinical symptoms 
3.4.3. Diagnosis  
3.4.4. Hemorrhoids 
3.4.5.  Vulvar Varicose Veins 

3.5. Perinatal Hemolytic Disease.  

3.5.1. Concept 
3.5.2. Pathophysiology. 
3.5.3. Rh Isoimmunization 
3.5.4. ABO Isoimmunization 

3.6. Thromboembolic Disease in Pregnancy and Puerperium: Deep Vein Thrombosis and Pulmonary Thromboembolism.  

3.6.1. Aetiopathogenesis and Risk Factors 
3.6.2. Treatment 

3.7. Pregnant with Heart Disease. Cardiac Examination in Pregnancy 

3.7.1.  Cardiac Modifications in Pregnancy 
3.7.2. Epidemiology of Cardiac Pathology in Pregnancy 
3.7.3. Classification of the Risk of Heart Disease in Pregnancy 
3.7.4. Preconception Counseling for Pregnant Women with Heart Disease 
3.7.5. Situations that May Hinder Pregnancy 
3.7.6. Management and Choice of the Route of Delivery 

3.8. Pregnant Women with Valvulopathies 

3.8.1. Mitral Estenosis 
3.8.2. Aortic Stenosis 
3.8.3. Mitral Insufficiency 
3.8.4. Aortic Insufficiency 
3.8.5. Tricuspid Regurgitation 
3.8.6. Valve Prosthesis 

3.9.  Arrhythmias in Pregnancy 

3.9.1.  Paroxysmal Supraventricular Tachycardia 
3.9.2. Atrial Fibrillation 
3.9.3. Ventricular Arrhythmias 
3.9.4. Bradyarrhythmias 

3.10. The Pregnant Woman with Congenital Cardiac Pathology:  

3.10.1. Tetralogy of Fallot 
3.10.2. Coarctation of Aorta 
3.10.3. Marfan Syndrome. 
3.10.4. Single Ventricle 
3.10.5. Fontan 
3.10.6. The Pregnant Woman with Cardiac Transplant.

Module 4. Pregnant with Neurological, Musculoskeletal, Dermatological and Autoimmune Problems

4.1. Epilepsy

4.1.1. Clinical Management and Treatment Compatible with Gestation: Preconception Counseling
4.1.2. Effects of Epilepsy on Pregnancy
4.1.3. Effects of Pregnancy on Epilepsy
4.1.4. Treatment of Crises During Childbirth
4.1.5. Newborn of an Epileptic Mother: Malformations and Congenital Anomalies

4.2. Multiple Sclerosis (MS)

4.2.1. Effects of MS in Pregnancy
4.2.2. Effects of Pregnancy on MS 
4.2.3. Clinical Management During Gestation and Pharmacotherapy
4.2.4. Clinical Management During Labor
4.2.5. The Postpartum Period in Women with Multiple Sclerosis

4.3. Peripheral Neuropathies

4.3.1. Carpal Tunnel Syndrome
4.3.2. Radiculopathies: Lumbalgias and Sciaatalgia
4.3.3. Herniated Disc
4.3.4. Bell's Palsy
4.3.5. Meralgia Paresthetica
4.3.6. Cyphoscoliosis

4.4. Spinal Cord Injuries

4.4.1. Clinical Management of Women with Spinal Cord Injuries During Pregnancy
4.4.2. Clinical Management During Labor. Epidural Analgesia
4.4.3. Specific Considerations During the Puerperium

4.5. Other Neurological Pathologies Present in Pregnancy 

4.5.1. Migraine and Headaches
4.5.2. Guillén-Barré Syndrome
4.5.3. Myasthenia Gravis
4.5.4. Cerebrovascular Diseases
4.5.5. Brain Neoplasms

4.6. Dermatological Problems During Pregnancy

4.6.1. Dermatological Changes During Pregnancy

4.6.1.1. Stretch Marks
4.6.1.2. Hyperpigmentation of Pregnancy: Melasma Gravidarum and Nevi

4.6.2. Vascular Changes

4.6.2.1. Spider Veins
4.6.2.2. Palmar Erythema
4.6.2.3. Haemangiomas

4.7. Specific Dermatopathies of Pregnancy

4.7.1. Herpes Gestationis

4.7.1.1. Clinical symptoms
4.7.1.2. Diagnosis
4.7.1.3. Differential Diagnosis
4.7.1.4. Prognosis
4.7.1.5. Treatment

4.7.2. Impetigo Herpetiformis

4.7.2.1. Clinical symptoms
4.7.2.2. Diagnosis
4.7.2.3. Differential Diagnosis
4.7.2.4. Prognosis
4.7.2.5. Treatment

4.7.3. Prurigo Gestationis

4.7.3.1. Clinical symptoms
4.7.3.2. Diagnosis
4.7.3.3. Differential Diagnosis
4.7.3.4. Prognosis
4.7.3.5. Treatment

4.7.4. Papular Dermatosis of Pregnancy

4.7.4.1. Clinical symptoms
4.7.4.2. Diagnosis
4.7.4.3. Differential Diagnosis
4.7.4.4. Prognosis
4.7.4.5. Treatment

4.7.5. Polymorphous Eruption of Pregnancy

4.7.5.1. Clinical symptoms
4.7.5.2. Diagnosis
4.7.5.3. Differential Diagnosis
4.7.56.4. Prognosis
4.7.5.5. Treatment

4.8. Systemic Lupus Erythematosus and Pregnancy

4.8.1. Preconception Screening
4.8.2. Control in Pregnancy

4.8.2.1. First Trimester
4.8.2.2. Second Trimester
4.8.2.3. Third Trimester

4.8.3. Childbirth and Puerperium

4.9. Antiphospholipid Syndrome (APS)

4.9.1. Concept
4.9.2. Pregestational Screening of Women with APS
4.9.3. Gestational Control of Women with APS
4.9.4. Treatment
4.9.5. Childbirth and Puerperium

4.10. Rheumatoid Arthritis:

4.10.1. Concept
4.10.2. How Rheumatoid Arthritis Affects Pregnancy
4.10.3. How Gestation Affects Rheumatoid Arthritis
4.10.4. Treatment

Module 5. Pregnant with Respiratory and Urological/Renal Problems. Tropical and Subtropical Diseases

5.1. Bronquial Asthma. 

5.1.1. Concept
5.1.2. Process of Bronchial Asthma During Pregnancy
5.1.3. Treatment
5.1.4. Asthmatic Crisis and Clinical Management
5.1.5. Considerations in the Delivery of a Pregnant Woman with Bronchial Asthma

5.2. Community-Acquired Pneumonia and Aspiration Pneumonia

5.2.1. Etiology 
5.2.2. Treatment
5.2.3. Specific Considerations During Pregnancy
5.2.4. Newborn of a Mother with Pneumonia

5.3. Flu

5.3.1. Etiology
5.3.2. Prevention
5.3.3. Considerations in Pregnancy
5.3.4. Treatment
5.3.5. Criteria for Hospitalization
5.3.6. Newborn of a Mother with Flu

5.4. Asymptomatic Bacteriuria

5.4.1. Concept
5.4.2. Etiology
5.4.3. Diagnostic Criteria
5.4.4. Treatment

5.5. Acute Cystitis and Urethral Syndrome

5.5.1. Concept
5.5.2. Etiology
5.5.3. Diagnostic Criteria
5.5.4. Treatment
5.5.5. Monitoring 

5.6. Acute Pyelonephritis

5.6.1. Concept
5.6.2. Clinical symptoms
5.6.3. Diagnosis
5.6.4. Treatment
5.6.5. Admission and Discharge Criteria
5.6.6. Complications

5.7. Obstructive Uropathy

5.7.1. Concept 
5.7.2. Clinical symptoms
5.7.3. Examination and Specific Tests
5.7.4. Diagnosis
5.7.5. Treatment
5.7.6. Complications

5.8. Renal Transplantation and Pregnancy

5.8.1. Effects of Transplantation on Pregnancy
5.8.2. Effects of Pregnancy on Transplantation
5.8.2. Considerations During Childbirth, Puerperium and Lactation

5.9. Tropical and Subtropical Diseases

5.9.1. Zika

5.9.1.1. Epidemiology
5.9.1.2. Transmission 
5.9.1.3. Clinical symptoms
5.9.1.4. Diagnosis
5.9.1.5. Fetal Impact and Congenital Zika Infection
5.9.1.6. Treatment and Prevention

5.9.2. Ebola

5.9.2.1. Epidemiology
5.9.2.2. Transmission 
5.9.2.3. Clinical symptoms
5.9.2.4. Diagnosis
5.9.2.5. Fetal Impact 
5.9.2.6. Treatment and Prevention

5.9.3. Chagas Disease: 

5.9.3.1. Epidemiology
5.9.3.2. Transmission 
5.9.3.3. Clinical symptoms
5.9.3.4. Diagnosis
5.9.3.5. Fetal Impact 
5.9.3.6. Treatment and Prevention

5.10. Tropical and Subtropical Diseases (II)

5.10.1. Dengue.

5.10.1.1. Epidemiology
5.10.1.2.Transmisión. 
5.10.1.3. Clinical symptoms
5.10.1.4. Diagnosis
5.10.1.5. Fetal Impact 
5.10.1.6. Treatment and Prevention

5.10.2. Malaria

5.10.2.1. Epidemiology
5.10.2.2. Transmission 
5.10.2.3. Clinical symptoms
5.10.2.4. Diagnosis
5.10.2.5. Fetal Impact 
5.10.2.6. Treatment and Prevention

5.10.3. Chikungunya

5.10.3.1. Epidemiology
5.10.3.2. Transmission 
5.10.3.3. Clinical symptoms
5.10.3.4. Diagnosis
5.10.3.5. Fetal Impact 
5.10.3.6. Treatment and Prevention

Module 6. Pathology of Fetal Growth and Gestational Duration. Immature Labor and Multiple Gestation. Pulmonary and Neurological Maturation

6.1. Intrauterine Growth Restriction (IGR)

6.1.1. Concept 
6.1.2. Pathogenesis and Etiological Factors
6.1.3. Prediction
6.1.4. Diagnosis and Classification
6.1.5. Differential Diagnosis with Small-for-Gestational-Age Fetus (SGAF)
6.1.6. Treatment and Completion of the Gestation 

6.2. Fetal Macrosomia

6.2.1. Concept
6.2.2. Risk factors
6.2.3. Monitoring and Obstetric Control
6.2.4. Completion of Pregnancy
6.2.5. Maternal and Fetal Complications

6.3. Chronologically Prolonged Gestation

6.3.1. Concept
6.3.2. Etiology and Prevention
6.3.3. Fetal Complications
6.3.4. Obstetrical Behavior
6.3.5. Induction in Week 41 Vs Week 42 

6.4. Premature birth

6.4.1. Threat of Preterm Labor

6.4.1.1. Concept and Risk Factors
6.4.1.2. Diagnosis: Ultrasound and Fibronectin Test
6.4.1.3. Obstetric Management and Tocolytic Treatment (Expanded in a Later Module)

6.4.2. Route of Delivery in the Premature Fetus and Specific Considerations

6.5.  Cervical Incompetence and Cerclage

6.5.1. Concept of Cervical Incompetence
6.5.2. Indications for Cervical Cerclage 
6.5.3. Cerclage Techniques
6.5.4. Pre- and Post-Cerclage Considerations
6.5.5. Complications
6.5.7. Cerclage Removal 

6.6. Suspected Chorioamnionitis and Clinical Chorioamnionitis

6.6.1. Concept of Chorioamnionitis
6.6.2. Criteria for Suspicion of Chorioamnionitis
6.6.3. Diagnosis
6.6.4. Treatment 
6.6.5. Specific Considerations in Birth 

6.7. Multiple Gestation

6.7.1. Concept and Classification
6.7.2. Fetal and Maternal Complications
6.7.3. Diagnosis and Determination of Chorionicity
6.7.4. Prenatal Diagnosis and Screening for Chromosomopathies
6.7.5. Gestational Control
6.7.6. Completion of Gestation and Route of Delivery 

6.8. Feto-Fetal Transfusion Syndrome

6.8.1.  Concept and Pathophysiology
6.8.2. Diagnostic Criteria
6.8.3. Differential Diagnosis 
6.8.4. Treatment

6.8.4.1. Technique of Laser Photocoagulation of Vascular Communications
6.8.4.2. Subsequent Follow-Up

6.9. Corticosteroid Therapy to Accelerate Fetal Lung Maturation

6.9.1. Concept 
6.9.2. Indications
6.9.3. Contraindications
6.9.4. Dosages
6.9.5. Specific Considerations According to Gestational Age
6.9.6. Special Situations

6.10. Magnesium Sulfate as a Fetal Neuroprotector.

6.10.1. Concept 
6.10.2. Indications
6.10.3. Contraindications
6.10.4. Drug Administration and Monitoring
6.10.5. Concomitant Use With Tocolytics in Threatened Preterm Labor
6.10.6. Side Effects:

Module 7. Pathology of the Placenta and Fetal Appendages. Obstetric Accidents

7.1. Placental Accretion

7.1.1. Concept and Forms of Accretion

7.1.1.1. Placenta Accreta
7.1.1.2. Placenta Enccreta
7.1.1.3. Placenta Percreta

7.1.2. Risk factors 
7.1.3. Symptoms and Morbimortality
7.1.4. Diagnosis
7.1.5. Clinical Management and Delivery of a Pregnant Woman with Placental Accreta

7.2. Placenta Previa

7.2.1. Concept
7.2.2. Classification
7.2.3. Risk factors
7.2.4. Symptoms and Morbimortality
7.2.5. Diagnosis
7.2.6. Management and Delivery of a Pregnant Woman with Placenta Previa

7.3.  Placental Morphologic and Functional Abnormalities

7.3.1. Size Alterations
7.3.2. Morphological Alterations

7.3.2.1. Bilobed Placenta
7.3.2.2. Circumvallate Placenta
7.3.2.3. Placenta Succenturiata
7.3.2.4. Espuria  

7.3.3. Placental Insufficiency

7.4. Umbilical Cord Anomalies

7.4.1. Variations of Umbilical Cord Length and its Complications: Knots and Circles
7.4.2. Umbilical Cord Anomalies in Relation to Presentation

7.4.2.1. Procubitus
7.4.2.2. Laterocidence
7.4.2.3. Prolapse

 7.4.2.3.1. Causes
 7.4.2.3.2. Cord Prolapse

7.4.3.  Placental Insertion Anomalies

7.4.3.1. Velamentous Insertion
7.4.3.2. Marginal Insertion
7.4.3.3. Previous Vasa

7.4.4. Vascular Anomalies

7.4.4.1. Thrombosis
7.4.4.2. Hematomas
7.4.4.3. Single Umbilical Artery

7.5. Alterations of the Amniotic Membranes

7.5.1. Amnion Nodosum
7.5.2. Amniotic Bands
7.5.3. Extramembranous Pregnancy
7.5.4. Premature Rupture of Membranes and Chorioamnionitis (Explained Above)

7.6. Amniotic Fluid Alterations

7.6.1. Default: Oligohydramnios and Anhydramnios

7.6.1.1. Concept and Epidemiology
7.6.1.2. Etiological Factors
7.6.1.3. Diagnosis
7.6.1.4. Fetal and Neonatal Impact
7.6.1.5. Clinical Management and Treatment

7.6.2. Excess: Polyhydramnios

7.6.2.1. Concept and Epidemiology
7.6.2.2. Etiological Factors
7.6.2.3. Diagnosis
7.6.2.4. Fetal and Neonatal Impact
7.6.2.5. Clinical Management and Treatment. Delivery Assistance

7.7. Uterine Rupture

7.7.1. Concept
7.7.2. Types
7.7.3. Risk factors
7.7.4. Clinical Diagnosis
7.7.5. Treatment

7.8. Normally Inserted Placenta Previa Detachment

7.8.1. Concept
7.8.2. Risk factors
7.8.3. Clinical Diagnosis
7.8.4. Clinical Management 

7.9. Amniotic Fluid Embolism

7.9.1. Concept
7.9.2. Risk factors
7.9.3. Pathophysiology.
7.9.4. Clinical symptoms
7.9.5. Diagnosis and Treatment

7.10. Shoulder Dystocia

7.10.1. Concept
7.10.2. Risk factors
7.10.3. Diagnosis
7.10.4. Solving Maneuvers

7.10.4.1. First Level Maneuvers
7.10.4.2. Second Level Maneuvers
7.10.4.3. Third Level Maneuvers
7.10.5. Postnatal Care and Assessment

Module 8. Variations in Normal Delivery and Onset of Labor. Mother Carrier of Streptococcus Group B

8.1. Instrumental Delivery

8.1.1. Concept
8.1.2. Indications
8.1.3. Contraindications
8.1.4. Criteria for Using the Different Instruments

8.1.4.1. Forceps
8.1.4.2. Thierry Spatulas
8.1.4.3. Cupping

8.2. Nalgae Delivery

8.2.1. Concept
8.2.2. Classification
8.2.3. Etiology
8.2.4. Diagnosis
8.2.5. Criteria for Vaginal Delivery and Management of Vaginal Delivery

8.3. Vaginal Delivery After a Cesarean Section

8.3.1. Choice of Delivery Route
8.3.2. Contraindications to Vaginal Delivery with Previous Cesarean Section
8.3.3. Planned Cesarean
8.3.4. Labor Induction

8.4. Obstetric Lesions of the Anal Sphincter

8.4.1. Prevention
8.4.2. Classification

8.4.2.1. Third-Degree Tear
8.4.2.2. Fourth-Degree Tear

8.4.3 Reparation of Perineal Tears
8.4.4. Follow-Up and Delivery After Anal Sphincter Injury

8.5. Cesarean Section

8.5.1. Indications
8.5.2. Classification
8.5.3. Considerations Prior to a Cesarean Section
8.5.4. Surgical Technique
8.5.5. Post-Operative Care

8.6. External Cephalic Version

8.6.1. Concept
8.6.2. Indications
8.6.3. Contraindications
8.6.4. Technique and Full Procedure
8.6.5. Complications

8.7. Cervical Maturation and Induction of Labor

8.7.1. Concept
8.7.2. Indications
8.7.3. Contraindications
8.7.4. Risks of Induction
8.7.5. Methods for Inducing Labor

8.7.5.1. Pharmacological Methods
8.7.5.2. Non-Pharmacological Methods

8.8. Fetal Hydrops

8.9.1. Concept

8.9.1.1. Immune Hydrops
8.9.1.2. Non-Immune Hydrops

8.9.2. Pathophysiology.
8.9.3 Diagnosis
8.9.4. Clinical Management 

8.9. Mother Carrier of Streptococcus Group B (SGB)

8.9.1. Concept
8.9.2. Screening and Sample Collecting
8.9.3. Treatment
8.9.4. Care of Newborns of SGB Carrier Mother 

8.10. Early Membrane Tear 

8.10.1. Etiology
8.10.2. Diagnosis
8.10.3. Early Pre-Term Membrane Tear 
8.10.4. Early Tear of Membranes at Term

Module 9. Dermatological Problems During Pregnancy. Gynecologic Cancer and Pregnancy. Hypertensive Disorders of Pregnancy

9.1. Thyroid Pathology and Pregnancy

9.1.1. Hypothyroidism

9.1.1.1. Diagnosis
9.1.1.2. Clinical symptoms
9.1.1.3. Etiology
9.1.1.4. Clinical Management     

9.1.2. Hyperthyroidism and Thyrotoxicosis

9.1.2.1. Diagnosis
9.1.2.2. Clinical symptoms
9.1.2.3. Etiology
9.1.2.4. Clinical Management     

9.1.3. Treatment During Pregnancy
9.1.4. Fetal Impact

9.2. Diabetes Mellitus and Pregnancy 

9.2.1. Pregestational Management
9.2.2. Gestational Control
9.2.3. Pregnancy Termination Criteria
9.2.4. Considerations During Pregnancy
9.2.5. Newborn of a Mother with Diabetes Mellitus

9.3. Gestational Diabetes

9.3.1. Concept 
9.3.2. Risk factors
9.3.3. Diagnosis and Screening Protocol
9.3.4. Gestational Control
9.3.5. Criteria for Terminating the Gestation
9.3.6. Clinical Management During Labor and Post-Partum
9.3.7. Newborn of a Mother with Gestational Diabetes

9.4. Obesity and Pregnancy

9.4.1. Concept and Classification of Obesity
9.4.2. Impact of Obesity on Gestation
9.4.3. Impact of Gestation on Obesity
9.4.4. Obese Mother and Puerperium

9.5. Breast Cancer and Pregnancy

9.5.1. Concept and Epidemiology
9.5.2. Diagnosis
9.5.3. Treatment
9.5.4. Prognosis

9.6. Cervical Cancer and Pregnancy

9.6.1. Concept and Epidemiology
9.6.2. Cytology in Pregnancy
9.6.3. Colposcopy During Pregnancy
9.6.4. Diagnosis and Treatment

9.7. Ovary Cancer and Pregnancy

9.7.1. Concept and Epidemiology
9.7.2. Clinical symptoms
9.7.3. Diagnosis
9.7.4. Treatment

9.8. Hypertensive Disorders of Pregnancy (I)

9.8.1. Concept
9.8.2. Classification of Hypertension in Pregnancy
9.8.3. Severity Criteria
9.8.4. Prediction and Prevention
9.8.5. Treatment and Clinical Handling
9.8.6. Criteria for Terminating the Gestation

9.9. Hypertensive Disorders of Pregnancy (II)

9.9.1. Eclampsia

9.9.1.1. Diagnosis
9.9.1.2. Clinical Management and Treatment

9.9.2. Hellp Syndrome

9.9.2.1. Diagnosis
9.9.2.2. Clinical Management and Treatment

9.9.3. Subsequent Follow-Up of Pregnant Women with Hypertension Problems

9.10. Antepartum Fetal Death

9.10.1. Concept
9.10.2. Classification
9.10.3. Etiological Factors
9.10.4. Diagnosis
9.10.5. Clinical and Psychological Management (Covered in Module 10)
9.10.6. Subsequent Genetic Counseling

Module 10. Psychological Problems During the Puerperium. Cardiopulmonary Resuscitation in Pregnant Women and Neonates. Legal Termination of Pregnancy

10.1. Puerperal Infection

10.1.1. Concept and Etiology
10.1.2. Risk factors
10.1.3. Ways of Propagation
10.1.4. Clinical Forms
10.1.5. Clinical symptoms
10.1.6. Treatment and Prophylaxis

10.2. Postpartum Hemorrhage

10.2.1. Concept
10.2.2. Etiology

10.2.2.1. Uterine Tone
10.2.2.2. Obstetric Trauma and Uterine Inversion
10.2.2.3. Tissue 
10.2.2.4. Coagulation Problems

10.2.3. Treatment

10.3. Main Issues with Breastfeeding

10.3.1. Nipple Cracks
10.3.2. Mammary Engorgement and Obstruction
10.3.3. Eczema and Candidiasis of the Nipple
10.3.4. Hypogalactia

10.4. Main Issues with Breastfeeding (II)

10.4.1. Acute Mastitis
10.4.1.1. Concept, Etiology and Symptoms
10.4.1.2. Prevention
10.4.1.3. Treatment
10.4.1.4. Complications

10.5. Psychological Problems During the Puerperium

10.5.1. Maternity Blues
10.5.2. Puerperal Depression 

10.5.2.1. Concept
10.5.2.2. Risk factors 
10.5.2.3. Prevention
10.5.2.4. Treatment

10.5.3. Puerperal Psychosis

10.5.3.1. Concept
10.5.3.2. Risk factors 
10.5.3.3. Prevention
10.5.3.4. Treatment

10.6. Perinatal Bereavement

10.6.1. Concept
10.6.2. Clinical manifestations
10.6.3. Types of Grief
10.6.4. Stages of Perinatal Grief
10.6.5. Psychological Handling

10.7. Post Dural Puncture Headache

10.7.1. Concept
10.7.2. Differential Diagnosis
10.7.3. Treatment and Prophylaxis
10.7.4. Complications

10.8. Cardiopulmonary Resuscitation in Pregnant Women

10.8.1. Main Causes of Cardio-Respiratory Arrest in Pregnant Women
10.8.2. Algorithm for Cardiopulmonary Resuscitation 
10.8.3. Specific Considerations of Pregnancy
10.8.4. Fetal Extraction

10.9. Neonatal Cardiopulmonary Resuscitation

10.9.1. Main Causes of Cardiorespiratory Arrest in Neonates
10.9.2. Algorithm for Cardiopulmonary Resuscitation
10.9.3. Neuroprotection with Hypothermia in the Neonate

10.9.3.1. Concept and Mechanism of Action of Hypothermia
10.9.3.2. Treatment Inclusion and Exclusion Criteria
10.9.3.3. Treatment and Cooling Phases
10.9.3.4. Limitation of Therapeutic Effort in Newborns with Hypoxic-Ischemic Encephalopathy

10.10. Legal Termination of Pregnancy

10.10.1. Concept
10.10.2. Legislative Framework
10.10.3. Methods According to Weeks of Gestation
10.10.4. Feticide

posgrado patologias embarazo matronas

A unique, key, and decisive training experience to boost your professional development”